Insider · CIK 0001775323
Jr. Mark L. Lupher
Files at ADVM (Adverum Biotechnologies, Inc.). First filing -, latest -.
In brief
Jr. Mark L. Lupher files SEC Form 4 as director at ADVM (Adverum Biotechnologies, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jr. Mark L. Lupher has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | UTender of shares Common Stock | -13,000 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -7,000 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right Buy)derivative | -4,500 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,000 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -4,000 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -4,000 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -4,000 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,520 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,450 | - | - | 0 | Dec 10, 2025 |
| Jun 17, 2025 | ADVM Adverum Biotechnologies, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,450 | $0.00 | $0 | 10,450 | Jun 20, 2025 |
Questions about Jr. Mark L. Lupher
Answered from the filings on this page, as of the latest one.
Is Jr. Mark L. Lupher buying or selling?
Jr. Mark L. Lupher has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jr. Mark L. Lupher's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jr. Mark L. Lupher has 0.
Where does Jr. Mark L. Lupher file Form 4?
Jr. Mark L. Lupher has filed Form 4 at ADVM (Adverum Biotechnologies, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.